Ascentis Independent Advisors
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1845003
DALLAS, TX
Position in ALNY
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$30,103
-$34,084 QoQ
Shares Held
100
-48.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#642
of 780 holders
Holding Since
Sep 2024
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ascentis Independent Advisors holds $30,103 across 1 Biotechnology name. ALNY ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
100 | $30,103 |
All Filings in ALNY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,103 | 100 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $64,187 | 194 | Shares | Sole | 2026-04-28 | |
| 2024-09-30 | $6,325 | 23 | Shares | Sole | 2024-10-29 | |
| No filing history on record for this holder in this stock. | ||||||